CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 61 filers reported holding CASI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | -36.8% | 9,757 | -20.2% | 0.00% | – |
| Q2 2021 | $19,000 | -85.7% | 12,228 | -77.9% | 0.00% | – |
| Q1 2021 | $133,000 | +111.1% | 55,269 | +159.0% | 0.00% | – |
| Q4 2020 | $63,000 | +37.0% | 21,341 | -28.3% | 0.00% | – |
| Q3 2020 | $46,000 | -37.0% | 29,773 | +0.5% | 0.00% | – |
| Q2 2020 | $73,000 | +114.7% | 29,626 | +78.0% | 0.00% | – |
| Q1 2020 | $34,000 | -78.2% | 16,646 | -67.0% | 0.00% | – |
| Q4 2019 | $156,000 | +88.0% | 50,431 | +102.9% | 0.00% | – |
| Q3 2019 | $83,000 | -20.2% | 24,859 | -23.5% | 0.00% | – |
| Q2 2019 | $104,000 | +160.0% | 32,510 | +130.5% | 0.00% | – |
| Q1 2019 | $40,000 | -63.6% | 14,103 | -40.2% | 0.00% | – |
| Q3 2018 | $110,000 | +254.8% | 23,598 | +525.3% | 0.00% | – |
| Q2 2018 | $31,000 | -83.9% | 3,774 | -91.8% | 0.00% | – |
| Q1 2018 | $193,000 | -11.1% | 46,200 | -30.8% | 0.00% | – |
| Q4 2017 | $217,000 | – | 66,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
| Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
| Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
| Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
| Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
| Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
| FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
| Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
| RBF Capital, LLC | 159,367 | $127,000 | 0.01% |